Clinical trial
COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)
NCT04492410 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 21, 2020
- Completion date
- November 12, 2021
- Enrollment
- 214 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer